OSIR

Osiris reports Q1 EPS (4c), consensus (4c)

moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click here to view […]

Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78%

[Business Wire] – Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets announced moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click here to view […]

OSIRIS THERAPEUTICS, INC. Financials

moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click here to view […]

Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care

[Business Wire] – Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets is pleased to announce the promotion of Frank D. moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, […]

The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference

[at noodls] – Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon New York, March 21, 2013 — The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International … moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click […]

Osiris Establishes Direct Sales Force for Grafix

[at noodls] – Osiris Therapeutics Establishes Direct Sales Force for Grafix® Clinical and commercial progress advance novel cell therapy in wound care COLUMBIA, Md. – March 1, 2013 – Osiris Therapeutics, Inc. (NASDAQ: … moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click here to view […]

Osiris receives European Orphan Drug designation for Prochymal

[at noodls] – Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® COLUMBIA, Md. – February 19, 2013 – Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company developing … moreView todays social media effects on OSIRView the latest stocks trending across Twitter. Click to view dashboardSee who Osiris is hiring next, click here to view […]